Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 2/20 | 0.35 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.32 |
| ▸ | XDH | P47989 | 1/20 | 0.31 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.31 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.30 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.30 |
| ▸ | MAT2A | P31153 | 1/20 | 0.30 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21546939 | 0.93 | ALDH1A3 (0.37) | PGRMEN1KMT2AALDH1A3 | |
| SCHEMBL21414147 | 0.93 | PGR (0.35) | PGRIMPDH2XDHSLC22A12CYP11B1 | |
| SCHEMBL19909088 | 0.92 | IRAK4 (0.32) | PGRPTGER4 | |
| SCHEMBL20617117 | 0.92 | RXRA (0.39) | PGRXDHCYP11B1CYP11B2 | |
| SCHEMBL19909519 | 0.91 | FLT3 (0.34) | PGRIMPDH2XDHCYP11B1CYP11B2 | |
| SCHEMBL19903696 | 0.91 | RXRA (0.38) | PGRXDHCYP11B1CYP11B2 | |
| SCHEMBL22822682 | 0.89 | RXRA (0.39) | PGRXDHCYP11B1CYP11B2 | |
| SCHEMBL22760961 | 0.89 | ALDH1A3 (0.39) | PGRXDHSLC22A12MEN1KMT2A | |
| SCHEMBL20619743 | 0.88 | CYP11B2 (0.42) | XDHCYP11B1CYP11B2 | |
| SCHEMBL21414140 | 0.88 | MEN1 (0.34) | PGRIMPDH2MEN1KMT2AATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11021473-B2 | Organic molecules for use in organic optoelectronic devices | CYNORA GMBH (DE) | 2021-06-01 | — | — | US | disclosed |
| US-20200399256-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11021473-B2 | Organic molecules for use in organic optoelectronic devices | OR10J3, OR51E2, OCIAD2 | PGR 3109/4885IMPDH2 833/4885XDH 430/4885 |
| US-20200399256-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, ORC3, AOC3 | PGR 3279/4885IMPDH2 3870/4885XDH 125/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.